Teradyne's analyst price target has been raised from $120.25 to $124.69. Analysts point to stronger test demand from AI accelerators and memory, along with increasing optimism for gains at major supply chain partners.
Analyst Commentary
Recent Street research on Teradyne reflects a broadly positive outlook, with several analysts raising their price targets and highlighting strong underlying business momentum. The commentary centers on the company’s strengthening position in critical areas of semiconductor testing. At the same time, some continued caution is noted as estimates and expectations are re-evaluated.
Bullish Takeaways- Bullish analysts are raising price targets significantly, reflecting strong conviction in Teradyne’s growth trajectory and market opportunity.
- Demand for test capacity related to AI accelerators, HBM, and mobile memory is expected to drive upward revisions in consensus earnings estimates for future years.
- Key wins and growing adoption at major industry players, particularly in AI compute supply chains, are leading to greater traction for Teradyne's advanced tester solutions.
- Recent company results have surpassed muted investor expectations. Momentum in new product areas like HBM4 and potential expansion in GPU testing further support the stock’s upward re-rating.
- Some analysts are expanding valuation multiples now without yet raising their earnings estimates. This underscores uncertainty about the timing and magnitude of the expected demand surge.
- Despite improved outlooks, at least one major firm maintains a conservative stance and highlights the need for continued execution as Teradyne seeks to penetrate new customer segments such as Nvidia.
- The stock’s near-term support is viewed as reliant on optionality rather than fully realized growth. This suggests execution risk remains as a consideration.
What's in the News
- Teradyne launched the ETS-800 D20, a high-performance test system for power semiconductors designed to serve both high-volume and high-mix/low-volume device testing needs. (Product-Related Announcement)
- The company introduced the Titan HP system level test platform, tailored for AI and cloud infrastructure markets and capable of supporting power demands up to four kilowatts in the future. (Product-Related Announcement)
- Teradyne released UltraPHY 224G for UltraFLEXplus, delivering next-generation high-speed PHY performance testing for data center and silicon photonics markets. (Product-Related Announcement)
- With the new Magnum 7H memory tester, Teradyne enables advanced testing for high bandwidth memory (HBM) used in AI servers and GPUs. This system achieves high parallelism and throughput. (Product-Related Announcement)
- Teradyne completed a share repurchase tranche and bought back 1,480,000 shares for $118.58 million as part of its ongoing buyback program. (Buyback Tranche Update)
Valuation Changes
- Consensus Analyst Price Target has risen modestly, increasing from $120.25 to $124.69 per share.
- Discount Rate has edged higher, moving from 9.97% to 10.08%.
- Revenue Growth projection remains virtually unchanged at approximately 13.22%.
- Net Profit Margin has improved slightly, up from 23.19% to 23.20%.
- Future P/E ratio has increased from 24.87x to 25.86x, reflecting higher valuation expectations.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.